查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917900

体外循环机市场－2026-2031年预测

Heart-Lung Machine Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计体外循环市场将以 6.64% 的复合年增长率成长，从 2025 年的 18.14 亿美元成长到 2031 年的 26.69 亿美元。

心肺体外迴圈（CPB）系统为核心的体外循环机市场是医疗设备业中至关重要且成熟的细分市场，在心臟直视手术和大型胸腔外科手术中提供必不可少的生命维持。这些复杂的系统能够暂时取代心臟和肺的功能——为血液供氧、清除二氧化碳并维持体循环——使外科医生能够在静止、无血的心臟上进行手术。作为心臟外科手术的基础技术，该市场的发展受到全球心血管疾病负担、灌注技术进步以及对不断变化的医疗外科和经济环境的策略调整的驱动。

市场需求的主要驱动因素是全球心血管疾病（CVD）持续高发生率。冠状动脉疾病、瓣膜疾病和先天性心臟疾病等疾病需要外科手术干预，例如冠状动脉绕道手术手术（CABG）、瓣膜修復或置换术以及复杂先天性心臟疾病矫正手术。所有这些手术通常都需要使用体外循环机，因此心血管疾病的发生率与需要使用体外循环机的手术数量之间存在直接且持续的相关性。全球人口老化是许多心臟病的主要风险因素，进一步强化了这种潜在需求。

持续的技术创新是塑造竞争格​​局并推动现有系统更新换代的关键趋势。创新主要集中在提高病人安全、改善生物相容性和优化手术流程等。关键研发领域包括：改进氧合器设计以改善气体交换并减少预充量；开发具有整合资料管理功能的先进监测和安全系统；以及研发更俱生物相容性的迴路涂层以最大限度地减少体外循环相关的发炎反应和併发症风险。这些创新旨在减少术后併发症并改善患者预后。

一个显着的市场趋势是携带式或小型体外循环机的研发和广泛应用。传统的体外循环主机是体积庞大的固定资产。新一代移动系统具有更高的柔软性，可用于混合手术室、院内急救转运或空间受限的场所。虽然价格通常较高，但这些可携式系统具有物流优势，并符合手术环境多样化的趋势。这有望扩大各种临床环境下获得先进心臟支援的机会。

就应用而言，心臟外科手术仍然是体外循环（CPB）应用的主要领域。该设备在大多数心臟直视手术中发挥着不可替代的作用，也是设有心臟外科计画的医院的重要资本投资。随着外科手术技术的拓展，纳入了更多复杂和高风险的患者群体，例如老年患者和合併多种疾病的患者，对可靠且先进的体外循环技术的需求也进一步增强，以确保手术安全。

从地理上看，北美凭藉其先进的医疗基础设施和庞大的心血管手术量，仍然是一个巨大的市场；而欧洲则是一个重要且稳定的市场，其特点是拥有完善的医疗保健体系、高标准的医疗服务以及对医疗技术的持续投入。欧洲市场受益于其对心血管健康的高度重视、完善的法规结构以及许多参与体外循环技术的主要医疗设备製造商的存在。

心臟外科医疗旅游正成为一种新兴趋势，尤其是在亚洲。一些国家拥有先进的医疗基础设施和尖端的外科手术技术，且费用低于西方国家，因此吸引了许多国际患者。这一趋势也推动了主要医院（作为医疗旅游中心）对尖端手术设备的需求，包括最先进的心臟氧合器。这些医院需要保持与世界一流技术的水平，才能保持竞争力。

竞争格局包括专注于体外循环技术的专业公司和产品组合涵盖重症监护领域的综合医疗设备製造商。竞争主要体现在技术领先性（例如，低预充量迴路、整合安全功能）、可靠性、易用性、为体外循环师提供的全面服务和培训支援以及总体拥有成本 (TCO) 等方面。鑑于心肺体外迴圈(CPB) 的高风险性，在安全性和临床支持方面拥有良好的过往记录至关重要。

市场参与企业的策略活动专注于持续投资研发，以推出具有更高安全性和更友善使用者介面的新一代系统。各公司也与领先的心臟中心合作进行临床研究，并根据实际手术和循环系统的回馈来改善产品设计。此外，他们致力于开发教育和培训项目，以培养操作这项复杂技术所需的专业循环系统团队。

总之，体外循环机市场对现代心臟外科手术至关重要，其需求受到全球心血管疾病负担的强力支撑。儘管这项技术已日趋成熟，但它并非一成不变，而是不断创新，透过提高生物相容性、安全性和操作柔软性来改善患者预后。未来市场发展将受到系统小型化和行动化、人工智慧在即时监测和决策支援方面的应用，以及在以价值为导向的医疗保健环境中对高性价比解决方案的需求等因素的影响。持续进行的心臟直视手术确保了心肺体外迴圈市场的长期存在，使其成为一项能够挽救生命并提高患者生活品质的关键技术。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要企业的策略倡议，并了解透过正确的策略进入市场的可能性。
  • 市场驱动因素和未来趋势：探索市场驱动因素和关键趋势，并了解它们将如何影响未来的市场发展。
  • 可操作的建议：利用这些见解，在动态环境中製定策略决策，发展新的业务流和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

报告的主要用途

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

第五章 依泵类型分類的体外循环市场

  • 介绍
  • 滚筒帮浦
  • 离心式帮浦

第六章 体外循环机市场：依应用领域划分

  • 介绍
  • 心臟移植
  • 肺移植
  • 心臟瓣膜手术
  • 其他的

第七章 依最终使用者分類的心肺旁路设备市场

  • 介绍
  • 医院
  • 心臟中心
  • 其他的

第八章 体外循环机市场：依地区划分

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Senko Medical Instrument Mfg. Co., Ltd.
  • LivaNova PLC
  • Heart Care India Co.
  • Terumo Corporation
  • Medtronic plc
  • Getinge AB
  • Century HLM
  • MicroPort Scientific Corporation

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615963

Heart-Lung Machine Market, with a 6.64% CAGR, is anticipated to reach USD 2.669 billion in 2031 from USD 1.814 billion in 2025.

The heart-lung machine market, centered on cardiopulmonary bypass (CPB) systems, is a critical and mature segment within the medical device industry, providing essential life support during open-heart and major thoracic surgeries. These complex systems temporarily assume the functions of the heart and lungs-oxygenating blood, removing carbon dioxide, and maintaining systemic circulation-thereby allowing surgeons to operate on a still, bloodless heart. As a cornerstone technology enabling cardiac surgery, the market's evolution is driven by the global burden of cardiovascular disease, advancements in perfusion technology, and strategic adaptations to the changing surgical and economic landscape of healthcare.

The primary and most fundamental driver of market demand is the persistent and high global prevalence of cardiovascular diseases (CVDs). Conditions such as coronary artery disease, valvular heart disease, and congenital heart defects necessitate surgical interventions like coronary artery bypass grafting (CABG), valve repair or replacement, and complex congenital corrections. Each of these procedures typically requires cardiopulmonary bypass, creating a direct and sustained correlation between the incidence of CVDs and the procedural volume requiring heart-lung machines. The aging global population, a key risk factor for many cardiac conditions, further solidifies this underlying demand.

Continuous technological advancement is a key trend shaping the competitive landscape and driving the replacement cycle for existing systems. Innovation focuses on enhancing patient safety, improving biocompatibility, and optimizing surgical workflows. Key areas of development include the refinement of oxygenator designs for improved gas exchange and reduced priming volumes, advanced monitoring and safety systems with integrated data management, and the development of more biocompatible circuit coatings to minimize the inflammatory response and risk of complications associated with CPB. These innovations aim to reduce post-operative morbidity and support better patient outcomes.

A significant trend within the market is the development and increasing adoption of portable or compact heart-lung machines. Traditional CPB consoles are large, fixed pieces of capital equipment. Newer, more mobile systems offer greater flexibility, allowing for use in hybrid operating rooms, during emergency transport within a hospital, or in facilities with space constraints. While often representing a premium segment, these portable systems provide logistical advantages and support the trend toward more versatile surgical environments, potentially expanding access to advanced cardiac support in varied clinical settings.

From an application perspective, cardiac surgery remains the dominant and defining segment for heart-lung machine utilization. The device's role is irreplaceable in most open-heart procedures, making it a mandatory capital investment for hospitals with cardiac surgery programs. The expansion of surgical techniques to include more complex and high-risk patient populations, including older adults and those with multiple comorbidities, reinforces the need for reliable and advanced CPB technology to ensure procedural safety.

Geographically, while North America remains a large market due to its advanced healthcare infrastructure and high volume of cardiac procedures, Europe represents a significant and stable market characterized by well-established healthcare systems, high standards of care, and ongoing investment in medical technology. The European market benefits from a strong focus on cardiovascular health, supportive regulatory frameworks, and the presence of leading medical device manufacturers engaged in perfusion technology.

An emerging dynamic influencing certain regions, particularly in Asia, is the growth of medical tourism for cardiac surgery. Countries that have invested in high-quality healthcare infrastructure and offer advanced surgical capabilities at a lower cost than Western nations are attracting international patients. This trend drives demand for state-of-the-art surgical equipment, including modern heart-lung machines, in leading hospitals within these medical tourism hubs, as they must maintain technology parity with global standards to remain competitive.

The competitive environment includes specialized companies focused on perfusion technology and broader medical device corporations with critical care portfolios. Competition is based on technological leadership (e.g., low-priming volume circuits, integrated safety features), reliability, ease of use, comprehensive service and training support for perfusionists, and the total cost of ownership. Given the high-stakes nature of CPB, a proven track record of safety and clinical support is paramount.

Strategic activities by market participants emphasize sustained investment in research and development to introduce next-generation systems with enhanced safety profiles and user interfaces. Companies also engage in collaborations with leading cardiac centers to conduct clinical research and refine product design based on real-world surgical and perfusionist feedback. Furthermore, there is a focus on developing educational and training programs to support the specialized perfusionist workforce essential for operating this complex technology.

In conclusion, the heart-lung machine market is integral to the practice of modern cardiac surgery, with demand firmly anchored in the global burden of cardiovascular disease. While a mature technology, it is not static; innovation continues to focus on improving patient outcomes through enhanced biocompatibility, safety, and operational flexibility. Future market development will be influenced by the miniaturization and mobilization of systems, the integration of artificial intelligence for real-time monitoring and decision support, and the need for cost-effective solutions in value-based healthcare environments. The market's enduring role is assured by the continued necessity for open-heart surgery, ensuring that cardiopulmonary bypass remains a vital technology in saving and improving lives.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Heart-Lung Machine Market Segmentation

  • By Pump Type
  • Roller Pump
  • Centrifugal Pump
  • By Application
  • Heart Transplant
  • Lung Transplant
  • Heart Valve Surgery
  • Others
  • By End-User
  • Hospitals
  • Cardiac Centers
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. HEART-LUNG MACHINE MARKET BY PUMP TYPE

  • 5.1. Introduction
  • 5.2. Roller Pump
  • 5.3. Centrifugal Pump

6. HEART-LUNG MACHINE MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Heart Transplant
  • 6.3. Lung Transplant
  • 6.4. Heart Valve Surgery
  • 6.5. Others

7. HEART-LUNG MACHINE MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Cardiac Centers
  • 7.4. Others

8. HEART-LUNG MACHINE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Senko Medical Instrument Mfg. Co., Ltd.
  • 10.2. LivaNova PLC
  • 10.3. Heart Care India Co.
  • 10.4. Terumo Corporation
  • 10.5. Medtronic plc
  • 10.6. Getinge AB
  • 10.7. Century HLM
  • 10.8. MicroPort Scientific Corporation

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations